- Home
- ABAT vs PMVP Comparison
ABAT vs PMVP Comparison
Compare ABAT & PMVP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ABAT
- PMVP
- Stock Information
- Founded
- ABAT 2011
- PMVP 2013
- Country
- ABAT United States
- PMVP United States
- Employees
- ABAT N/A
- PMVP N/A
- Industry
- ABAT Metal Mining
- PMVP Medicinal Chemicals and Botanical Products
- Sector
- ABAT Basic Materials
- PMVP Health Care
- Exchange
- ABAT Nasdaq
- PMVP Nasdaq
- Market Cap
- ABAT 71.7M
- PMVP 85.5M
- IPO Year
- ABAT N/A
- PMVP 2020
- Fundamental
- Price
- ABAT $0.98
- PMVP $1.50
- Analyst Decision
- ABAT
- PMVP Strong Buy
- Analyst Count
- ABAT 0
- PMVP 4
- Target Price
- ABAT N/A
- PMVP $5.75
- AVG Volume (30 Days)
- ABAT 586.7K
- PMVP 196.4K
- Earning Date
- ABAT 11-15-2024
- PMVP 11-07-2024
- Dividend Yield
- ABAT N/A
- PMVP N/A
- EPS Growth
- ABAT N/A
- PMVP N/A
- EPS
- ABAT N/A
- PMVP N/A
- Revenue
- ABAT $545,460.00
- PMVP N/A
- Revenue This Year
- ABAT $31,748.62
- PMVP N/A
- Revenue Next Year
- ABAT N/A
- PMVP N/A
- P/E Ratio
- ABAT N/A
- PMVP N/A
- Revenue Growth
- ABAT N/A
- PMVP N/A
- 52 Week Low
- ABAT $0.73
- PMVP $1.40
- 52 Week High
- ABAT $6.45
- PMVP $3.47
- Technical
- Relative Strength Index (RSI)
- ABAT 61.18
- PMVP 38.59
- Support Level
- ABAT $0.83
- PMVP $1.55
- Resistance Level
- ABAT $1.08
- PMVP $1.61
- Average True Range (ATR)
- ABAT 0.09
- PMVP 0.07
- MACD
- ABAT 0.01
- PMVP -0.01
- Stochastic Oscillator
- ABAT 57.32
- PMVP 18.18
About ABAT American Battery Technology Company
American Battery Technology Co is engaged in lithium-ion battery recycling, battery metals and material extraction, and resource production. It is a battery metals company producing low-cost battery metals with a commitment to closed-loop, clean energy technologies.
About PMVP PMV Pharmaceuticals Inc.
PMV Pharmaceuticals Inc is a precision oncology company. The company is engaged in the research and development of small molecule, tumor-agnostic therapies targeting p53 mutations, which has the ability to eliminate cancer cells.